Evolent Health Inc
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 75.7% | 81.7% | 83.7% | 83.5% | 87.0% | 88.3% | 78.8% | 82.7% | 84.2% | 88.9% | 87.5% | 87.6% | 87.1% | |
| 24.3% | 18.3% | 16.3% | 16.5% | 13.0% | 11.7% | 21.2% | 17.3% | 15.8% | 11.1% | 12.5% | 12.4% | 12.9% | |
| 1.3% | 1.2% | 1.0% | 1.0% | – | – | – | – | 0.0% | – | – | – | – | |
| 15.8% | 32.4% | 12.4% | 10.7% | 10.8% | 12.2% | 16.2% | 16.9% | 16.2% | 15.5% | 14.7% | 10.5% | 13.9% | |
| 27.9% | 22.1% | 18.4% | 15.3% | 15.6% | 14.6% | 21.5% | 16.7% | 15.7% | 13.2% | 14.5% | 13.9% | 14.3% | |
| -3.5% | -3.8% | -2.1% | 1.2% | -2.6% | -2.9% | -0.3% | 0.6% | 0.1% | -2.1% | -2.0% | -1.5% | -1.4% | |
| 2.9% | 2.2% | 0.9% | 0.9% | 1.0% | 1.0% | 2.1% | 2.6% | 3.4% | 4.1% | 3.4% | 2.6% | 3.3% | |
| -6.0% | -8.6% | -2.6% | 0.2% | -3.8% | -3.7% | -13.1% | -4.7% | -4.2% | -91.9% | -5.2% | -3.9% | -23.9% | |
| -1.1% | -2.6% | 0.1% | 0.0% | -0.1% | -0.2% | 0.3% | -0.2% | 0.2% | -0.4% | 0.2% | 0.4% | 0.1% | |
| -5.0% | -6.0% | -2.7% | 0.2% | -3.7% | -3.5% | -13.4% | -4.5% | -4.4% | -91.6% | -5.4% | -4.3% | -24.1% | |
| 3.6% | -1.1% | 2.9% | 5.6% | 1.9% | 2.1% | -5.9% | 3.4% | 4.9% | -78.2% | 2.7% | 2.0% | -15.1% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.